Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

551
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
551
Potential Energy00:52

Potential Energy

42.7K
The energy stored by a structure and location of matter in space is called potential energy. For instance, raising a kettlebell changes its spatial location and increases its potential energy. Similarly, a stretched rubber band contains potential energy which, under certain conditions, can be converted into other forms of energy, such as kinetic energy.
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
42.7K
Potential Energy01:09

Potential Energy

999
A conservative force, such as a gravitational or elastic force, gives the body the capacity to do work. This capacity, measured as the potential energy, depends on the body's location or “position” relative to a fixed reference position or datum. The gravitational potential energy is considered zero at the reference point. Suppose a body is located at some vertical distance above a fixed horizontal reference or datum. In that case, the weight of the body has positive gravitational potential...
999
Subviral Agents01:29

Subviral Agents

559
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
559
Standard Electrode Potentials03:02

Standard Electrode Potentials

50.3K
On comparing the reactivity of silver and lead, it is observed that the two ionic species, Ag+ (aq) and Pb2+ (aq), show a difference in their redox reactivity towards copper: the silver ion undergoes spontaneous reduction, while the lead ion does not. This relative redox activity can be easily quantified in electrochemical cells by a property called cell potential. This property is commonly known as cell voltage in electrochemistry, and it is a measure of the energy which accompanies the charge...
50.3K
Cell Potential and Free Energy02:58

Cell Potential and Free Energy

46.5K
Thermodynamics of a Redox Reaction
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
46.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prebiotic inulin affects virulence factor expression in <i>Candida albicans</i>.

mBio·2026
Same author

Oral Administration of Crocus sativus Tepals Extract Restores High-Fat Diet-Induced Gut Dysbiosis and Modulates Intestinal Inflammation and Hepatic Lipid Metabolism.

BioFactors (Oxford, England)·2026
Same author

European Teas (<i>Camellia sinensis</i>) as a New Frontier in the Specialty Tea Market: Characterizing the Antioxidant, Polyphenolic, and Sensory Profiles Through a Systematic, Comparative Approach.

Antioxidants (Basel, Switzerland)·2026
Same author

Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference Workshops.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Effects of Methylglyoxal on Intestinal Cells: Insights on Epigenetic Regulatory Enzymes.

IUBMB life·2025

Related Experiment Video

Updated: Jan 31, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K

Repurposing of idebenone as a potential anti-cancer agent.

Elisabetta Damiani1, Raif Yuecel2, Heather M Wallace3

  • 1School of Medicine, Medical Sciences and Nutrition, Institute of Medical Science, University of Aberdeen, Aberdeen, U.K.

The Biochemical Journal
|January 4, 2019
PubMed
Summary

Idebenone (IDE), a Coenzyme Q10 analogue, shows potential as a novel glioblastoma (GB) treatment. IDE reduced GB cell viability and migration, suggesting its repurposing for cancer therapy.

Keywords:
anti-migrationanti-proliferationgliomaidebenonep21-activated kinases

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

17.0K

Related Experiment Videos

Last Updated: Jan 31, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

17.0K

Area of Science:

  • Neuro-oncology
  • Pharmacology
  • Biochemistry

Background:

  • Glioblastoma (GB) is an aggressive primary brain tumor with high mortality.
  • Current treatments have limited efficacy, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of idebenone (IDE), a Coenzyme Q10 analogue, as a chemotherapeutic agent for glioblastoma.
  • To evaluate IDE's effects on glioblastoma cell proliferation, migration, and apoptosis.

Main Methods:

  • Utilized two glioblastoma cell lines (U373MG and U87MG).
  • Assessed IDE's impact on cell viability, cytotoxicity in combination with temozolomide and oxaliplatin.
  • Evaluated effects on clonogenic and migratory capacity.
  • Analyzed cell cycle regulation (p21 expression, flow cytometry) and apoptosis (caspase-3 expression, Annexin V/propidium iodide staining).

Main Results:

  • IDE decreased viable glioblastoma cell numbers and enhanced the cytotoxic effects of temozolomide and oxaliplatin.
  • IDE reduced clonogenic and migratory potential in both cell lines at safe concentrations.
  • IDE induced S-phase arrest in U373MG cells and apoptosis in U373MG cells, indicated by decreased p21 and caspase-3 expression, respectively.
  • Apoptotic effects were less pronounced in U87MG cells.

Conclusions:

  • Idebenone demonstrates anti-proliferative and anti-migratory properties against glioblastoma cells.
  • IDE may be a viable candidate for glioblastoma treatment, potentially through cell cycle dysregulation and apoptosis induction.
  • Synergistic combinations of IDE with other agents show promise for glioblastoma therapy.